Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials
Jie Wen, Zhenjie Yi, Yuyao Chen, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Association of metformin use and cancer incidence: a systematic review and meta-analysis
Lauren E. O’Connor, Maeve Bailey‐Whyte, Manami Bhattacharya, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 4, pp. 518-529
Closed Access | Times Cited: 22
Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
Xiaoting Zhou, Biao An, Yi Lin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115036-115036
Open Access | Times Cited: 39
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 8
Efficacy of metformin and verteporfin treatment alone or in combination in a murine head and neck cancer xenograft model
Ashley Shan, Khin Swe Hlaing, Asada Leelahavanichkul, et al.
European Journal Of Oral Sciences (2025)
Closed Access
Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment
Carla Micaela Cuttica, Irene Maria Briata, Andrea DeCensi
Nutrients (2023) Vol. 15, Iss. 17, pp. 3737-3737
Open Access | Times Cited: 10
The impact of metformin on mortality in patients with type 2 diabetes mellitus: a prospective cohort study
Bocheng Zhang, Ying Cao, Zhenan Qu, et al.
Endocrine (2024)
Closed Access | Times Cited: 3
Insulin resistance and cancer: molecular links and clinical perspectives
Alfredo Caturano, Enes Erul, Roberto Nilo, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Dietary approaches for controlling cancer by limiting the Warburg effect: a review
Ghazaleh Shimi
Nutrition Reviews (2023) Vol. 82, Iss. 9, pp. 1281-1291
Closed Access | Times Cited: 7
Senotherapy, cancer, and aging
Lodovico Balducci, Claire Falandry, S. Monfardini
Journal of Geriatric Oncology (2023) Vol. 15, Iss. 4, pp. 101671-101671
Closed Access | Times Cited: 6
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice
Saadia Zahid, Alcir Luiz Dafré, António Currais, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6828-6828
Open Access | Times Cited: 5
Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
Alessia Greco, Francesca Coperchini, Laura Croce, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
A metformina como uma droga coadjuvante no tratamento de diversos tipos de cânceres: uma revisão integrativa da literatura
Rodrigo Daniel Zanoni, Camila Raffa Reinalde, Vitor Barbosa Vieira, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 2600-2611
Open Access | Times Cited: 1
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR Signaling Pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Authorea (Authorea) (2024)
Open Access | Times Cited: 1
Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients
Francesca Ligorio, Andrea Vingiani, Tommaso Torelli, et al.
Cell Metabolism (2024)
Closed Access | Times Cited: 1
Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy
Abduldaheem Turki Jalil, Hassan Hadi Al-Kazzaz, Firas Hassan, et al.
Indian Journal of Clinical Biochemistry (2024) Vol. 40, Iss. 2, pp. 165-175
Closed Access
Correlation Between Glycemic Control and Serum Thyroglobulin Levels in a Patient With RAI-Refractory Thyroid Cancer
Yuji Hataya, Takumi Nomura, Yuko Fujishima, et al.
JCEM Case Reports (2024) Vol. 2, Iss. 5
Open Access
Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma
Tong Zhou, Xuefeng Zhang, Dan Yang, et al.
Oral Diseases (2024)
Closed Access
An anti-neoplastic tale of metformin through its transport
Firoz Khan Bhati, Manoj Kumar Bhat
Life Sciences (2024), pp. 123060-123060
Closed Access
Exploring the Basic Molecular Pathways: Metformin as a Potential Treatment Option for Pancreatic Cancer
Sepehr Ramezani, Dariush Moslemi, Faezeh Firuzpour, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 4, pp. 56-68
Closed Access
Effect of metformin on the prognosis of chemoradiotherapy cancer patients: a systematic review and meta-analysis of randomized controlled trials and cohort studies
Da Wang, Penglai Zhao, Xiaohua Dong, et al.
Research Square (Research Square) (2023)
Open Access
Statin Use and Chemoradiation in Esophageal Squamous Cell Carcinomas: Ready for Prime Time?
Steven H. Lin
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 8, pp. 970-971
Open Access
Effects of Metformin on Transcriptomic and Metabolomic Profiles in Breast Cancer Survivors Enrolled in the Randomized Placebo-Controlled MetBreCS Trial
Pouda Panahandeh Strømland, Bjørn-Erik Bertelsen, Kristin Viste, et al.
Research Square (Research Square) (2023)
Open Access
Reply to “Metformin as a booster or obstacle of immunotherapy in patients with non–small cell lung cancer and diabetes mellitus”
Yasmin Leshem, Yardenna Dolev, Nava Siegelmann‐Danieli, et al.
Cancer (2023) Vol. 130, Iss. 2, pp. 324-324
Closed Access
Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway
Yingxuan Sun, Jianhua Cheng, Ding Nie, et al.
Molecular and Cellular Endocrinology (2023) Vol. 582, pp. 112140-112140
Closed Access
Effectiveness of the alternative drugs and other factors in adjuvant treatment for the malignant tumors
В. А. Чубенко
Practical oncology (2023) Vol. 23, Iss. 4, pp. 383-394
Open Access
Page 1

Scroll to top